| 1 |
34837219 | Pathophysiological metabolic changes associated with disease modify the proarrhythmic risk profile of drugs with potential to prolong repolarisation. | 2022 Jun |
2 |
| 2 |
34863995 | In vitro ion channel profile and ex vivo cardiac electrophysiology properties of the R(-) and S(+) enantiomers of hydroxychloroquine. | 2022 Jan 15 |
2 |
| 3 |
33345848 | Off-label use of chloroquine, hydroxychloroquine, azithromycin and lopinavir/ritonavir in COVID-19 risks prolonging the QT interval by targeting the hERG channel. | 2021 Feb 15 |
2 |
| 4 |
33674391 | COVID-19 Drugs Chloroquine and Hydroxychloroquine, but Not Azithromycin and Remdesivir, Block hERG Potassium Channels. | 2021 May |
3 |
| 5 |
34058295 | Computational and experimental studies on the inhibitory mechanism of hydroxychloroquine on hERG. | 2021 Jun 30 |
2 |
| 6 |
17574068 | Missing the bull's eye. | 2007 Jul-Aug |
1 |